Skip to main content

Table 4 Patients’ and controls’ different types of osteoprotegerin (OPG) rs3102735 polymorphism

From: Role of osteoprotegerin rs3102735 gene polymorphism in acute ischemic stroke patients

OPG rs3102735 polymorphism

Patients (n = 50)

Controls (n = 50)

Test of sig.

p

χ2

CC

36 (72.0%)

28 (56.0%)

2.778

0.096

CT

13 (26.0%)

15 (30.0%)

0.198

0.656

TT

1 (2.0%)

7 (14.0%)

5.029*

0.031*

CC + CT

49 (98.0%)

43 (86.0%)

4.891*

0.041*

C allele

85 (85.0%)

71 (71.0%)

5.711*

0.017*

T allele

15 (15.0%)

29 (29.0%)

  1. OPG osteoprotegerin, C cytosine nucleotide, T thiamine nucleotide, χ2 Chi square test
  2. *Statistically significant at p ≤ 0.05